References
- Ducommun B, Draetta G, Young P, Beach D. Fission yeast cdc25 is a cell-cycle regulated protein. Biochem Biophys Res Commun 1990;167:301–9
- Rudolph J. Cdc25 phosphatases: structure, specificity, and mechanism. Biochemistry 2007;46:3595–604
- Boutros R, Lobjois V, Ducommun B. CDC25B involvement in the centrosome duplication cycle and in microtubule nucleation. Cancer Res 2007;67:11557–64
- Boutros R, Dozier C, Ducommun B. The when and wheres of CDC25 phosphatases. Curr Opin Cell Biol 2006;18:185–91
- Cangi MG, Cukor B, Soung P, et al. Role of the Cdc25A phosphatase in human breast cancer. J Clin Invest 2000;106:753–61
- Bonin S, Brunetti D, Benedetti E, et al. Expression of cyclin-dependent kinases and CDC25a phosphatase is related with recurrences and survival in women with peri- and post-menopausal breast cancer. Virchows Arch 2006;448:539–44
- Contour-Galcera MO, Lavergne O, Brezak MC, et al. Synthesis of small molecule CDC25 phosphatases inhibitors. Bioorg Med Chem Lett 2004;14:5809–12
- Brezak MC, Quaranta M, Mondésert O, et al. A novel synthetic inhibitor of CDC25 phosphatases: BN82002. Cancer Res 2004;64:3320–5
- Brezak MC, Valette A, Quaranta M, et al. IRC-083864, a novel bis quinone inhibitor of CDC25 phosphatases active against human cancer cells. Int J Cancer 2009;124:1449–56
- Brezak MC, Quaranta M, Contour-Galcera MO, et al. Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases. Mol Cancer Ther 2005;4:1378–87
- Pirrung MC, Deng L, Li Z, Park K. Synthesis of 2,5-dihydroxy-3-(indol-3-yl)benzoquinones by acid-catalyzed condensation of indoles with 2,5-dichlorobenzoquinone. J Org Chem 2002;67:8374–88
- Bana E, Sibille E, Valente S, et al. A novel coumarin-quinone derivative SV37 inhibits CDC25 phosphatases, impairs proliferation, and induces cell death. Mol Carcinogen 2015;54:229–41
- Pu L, Amoscato AA, Bier ME, Lazo JS. Dual G1 and G2 phase inhibition by a novel, selective Cdc25 inhibitor 6-chloro-7-[corrected](2-morpholin-4-ylethylamino)-quinoline-5,8-dione. J Biol Chem 2002;277:46877–85
- Hannewald P, Maunit B, Muller JF. Tubulin-binding drug screening by MALDI-TOFMS. Anal Chem 2006;78:4390–7
- Hannewald P, Maunit B, Muller JF. Screening of DHFR-binding drugs by MALDI-TOFMS. Anal Bioanal Chem 2008;392:1335–44
- Sibille E, Bana E, Chaouni W, et al. Development of a matrix-assisted laser desorption/ionization-mass spectrometry screening test to evidence reversible and irreversible inhibitors of CDC25 phosphatases. Anal Biochem 2012;430:83–91
- Huber-Villaume S, Revelant G, Sibille E, et al. 2-(Thienothiazolylimino)-1,3-thiazolidin-4-ones inhibit cell division cycle 25 A phosphatase. Bioorg Med Chem 2016;24:2920–8
- Rongved P, Kirsch G, Bouaziz Z, et al. Indenoindoles and cyclopentacarbazoles as bioactive compounds: synthesis and biological applications. Eur J Med Chem 2013;69:465–79
- Hundsdörfer C, Hemmerling H-J, Hamberger J, et al. Novel indeno[1,2-b]indoloquinones as inhibitors of the human protein kinase CK2 with antiproliferative activity towards a broad panel of cancer cell lines. Biochem Biophys Res Commun 2012;424:71–5
- Gozzi GJ, Bouaziz Z, Nacereddine A, et al. Converting potent indeno[1,2-b]indole inhibitors of protein kinase CK2 into selective inhibitors of the breast cancer resistance protein ABCG2. J Med Chem 2015;58:265–77
- Gozzi GJ, Bouaziz Z, Winter E, et al. Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and non-toxic inhibitors stimulating basal ATPase activity. Drug Discov Dev Ther 2015;9:3481–95
- Tandon VK, Kumar S. Recent development on naphthoquinone derivatives and their therapeutic applications as anticancer agents. Expert Opin Ther Patents 2013;23:1087–108
- Lavecchia A, Di Giovanni C, Novellino E. Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review. Expert Opin Ther Patents 2010;20:405–25
- Alchab F, Fenet B, Le Borgne M, et al. 1H and 13C NMR assignments of bioactive indeno[1,2-b]indole-10-one derivatives. Magn Reson Chem 2013;51:837–41
- Brault L, Denancé M, Banaszak E, et al. Synthesis and biological evaluation of dialkylsubstituted maleic anhydrides as novel inhibitors of Cdc25 dual specificity phosphatases. Eur J Med Chem 2007;42:243–7
- Valente S, Bana E, Viry E, et al. Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases. Bioorg Med Chem Lett 2010;20:5827–30
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63
- Alchab F, Ettouati L, Bouaziz Z, et al. Synthesis, biological evaluation and molecular modeling of substituted indeno[1,2-b]indoles as inhibitors of human protein kinase CK2. Pharmaceuticals (Basel) 2015;8:279–302
- Woodland A, Thompson S, Cleghorn LAT, et al. Discovery of inhibitors of Trypanosoma brucei by phenotypic screening of a focused protein kinase library. ChemMedChem 2015;10:1809–20
- Capasso A, Cerchia C, Di Giovanni C, et al. Ligand-based chemoinformatic discovery of a novel small molecule inhibitor targeting CDC25 dual specificity phosphatases and displaying in vitro efficacy against melanoma cells. Oncotarget 2015;6:40202–22
- Brenner AK, Reikvam H, Lavecchia A, Bruserud Ø. Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia-the possibility to target several kinases through inhibition of the various CDC25 isoforms. Molecules 2014;19:18414–47